November 29, 2021
SOGC Statement on IUC Self-Removal Trend on Social Media
November 29, 2021
SOGC Announces New CEO
November 16, 2021
Statement on the use of acetaminophen for analgesia and fever in pregnancy
November 15, 2021
SOGC Statement on COVID-19 Vaccination in Pregnancy
November 15, 2021
The SOGC launches a series of new initiatives to prevent maternal mortality in Canada
November 2, 2021
SOGC and CFWH Award Canadian Journalist for Excellence in Women's Health Reporting
October 19, 2021
The SOGC responds publicly to the coroner’s report on Joyce Echaquan’s death
October 18, 2021
The SOGC and CMS acknowledge World Menopause Day
October 18, 2021
The SOGC and CMS acknowledge World Menopause Day
August 6, 2021
SOGC proudly teams up with MD Financial Management and Scotiabank
June 29, 2021
Media Advisory: 2021 SOGC/CFWH Journalism Award for Excellence in Women's Health Reporting
June 29, 2021
Media Advisory: 2021 SOGC/CFWH Journalism Award for Excellence in Women's Health Reporting
June 18, 2021
Important Notice: Non-steroidal anti-inflammatory drugs (NSAIDs)
June 9, 2021
Labelling Notice: Non-steroidal anti-inflammatory drugs (NSAIDs)
June 4, 2021
SOGC Statement on Kamloops Residential School
May 13, 2021
Drug Shortage Notice: Magnesium Sulfate
April 21, 2021
SOGC Statement on the COVID-19 vaccines and rare adverse outcomes of thrombosis
April 15, 2021
SOGC statement regarding pregnant women and individuals with COVID-19 in ICUs in Ontario
April 9, 2021
Notice regarding the Depo-Provera Shortage
April 1, 2021
SOGC Statement on the AstraZeneca/COVISHIELD COVID-19 vaccines
March 19, 2021
SOGC Statement on Abortion Medication "Reversal"
March 18, 2021
SOGC statement on COVID-19 vaccination and fertility
February 15, 2021
SOGC Statement on Pregnant Workers during the COVID-19 Pandemic
February 15, 2021
Committee Opinion No. 400: COVID-19 and Pregnancy
December 15, 2020
Statement on Pediatric and Adolescent Gynecologic Care During and After the COVID-19 Pandemic
November 2, 2020
Health Canada: Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) beyond 20 weeks of pregnancy
October 19, 2020
SOGC releases joint statement with CAS and CPS
October 2, 2020
Update on ulipristal acetate:Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
September 28, 2020
SOGC Statement on Trial of Labour after Cesarean (TOLAC) Birth during the COVID-19 Pandemic
September 25, 2020
SOGC Statement on Access to Contraception
September 21, 2020
Updated Committee Opinion No. 400: COVID-19 and Pregnancy (July 27)
September 16, 2020
Call for Nominations: 2020 Mentorship Award
September 14, 2020
SOCG Clinical Expert Opinion in Response to European Medicines Agency Recommended Revocation of UPA
August 21, 2020
Nomination Form - 2020 SOGC Regional Achievement Awards
July 16, 2020
SOGC Update on Propylthiouracil (PTU) Shortage
June 23, 2020
SOGC statement in response to College des Médecins in Quebec’s report on urethral slings
June 17, 2020
SOGC Committee Opinion on Coercive Contraception Provision
June 8, 2020
SOGC Statement on Racism
June 5, 2020
SOGC Statement on the Shortage of PTU in Canada
June 4, 2020
Committee Opinion No. 400 – COVID-19 in Pregnancy (updated May 14, 2020)
June 1, 2020
Corticosteroids in COVID-19
May 27, 2020
SOGC Global Women's Health Committee Statement on the attack of a MSF Hospital
May 22, 2020
Prenatal Screening Update during the COVID-19 Pandemic
April 24, 2020
A Joint Statement on the Issue of Support Persons in Labour in Canada
April 9, 2020
Ulipristal Acetate Update 2020
April 8, 2020
Gestational Diabetes Screening During COVID-19 Pandemic
January 28, 2020
SOGC Infectious Disease Committee Statement on the Novel Coronavirus
December 19, 2019
Health Canada: GILENYA (fingolimod) - Risk of Congenital Malformations
November 15, 2019
Health Canada Advisory: PregVit and PregVit folic 5
November 15, 2019
SOGC Statement – Oxytocin Update (November 15)
November 15, 2019
SOGC Statement – Vaping and Pregnancy
October 11, 2019
SOGC Statement – Oxytocin Update
October 10, 2019
Health Canada Notice: Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
October 4, 2019
SOGC Statement – Oxytocin
September 10, 2019
SOGC Infectious Diseases Committee Statement on Dolutegravir Use in Pregnancy
August 29, 2019
Health Canada: Cymbalta and the risk of postpartum hemorrhage
July 24, 2019
SOGC Statement – Access to Medical Abortion in Canada: A Complex Problem to Solve
July 8, 2019
SOGC Infectious Disease Committee Statement on Syphilis
June 28, 2019
Congratulations to the 2019 ACSC Showcase Showdown and the Abstract Program “Best of Three” Winners
June 21, 2019
Health Canada Notice: ALERTEC (Modafinil) linked to risks of Congenital Anomalies
June 12, 2019
Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21
April 24, 2019
New Funding to Address Physician Wellness
March 28, 2019
Updated SOGC Statement on Maternal Sepsis
March 13, 2019
Statement from Chief Public Health Officer on Current Measles Outbreak and Vaccine Hesitancy
March 5, 2019
Drug Shortage Notification - DEMULEN 30 tablets (Updated)
February 20, 2019
SOGC Statement on the Use of Fluconazole during Pregnancy
January 18, 2019
SOGC Statement on Respectful Care
October 18, 2018
New Canadian Guideline Prescribes Exercise for Healthier Pregnant Women, Healthier Babies
October 17, 2018
Legal cannabis doesn't mean it's safe for pregnant women. Why risk it?
October 1, 2018
Unique collaboration to improve the safety of obstetrical and perinatal care in Canada
October 1, 2018
Canada Sets Goal to Become First Country in the World to Eliminate Cervical Cancer